HK Stock MarketDetailed Quotes

02162 KEYMED BIO-B

Watchlist
  • 41.950
  • -0.150-0.36%
Trading Dec 4 10:13 CST
11.73BMarket Cap-14415P/E (TTM)

KEYMED BIO-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Assets
Current assets
Inventory
4.35%83.93M
26.65%56.35M
111.82%80.43M
171.43%44.5M
84.84%37.97M
139.45%16.39M
--20.54M
107.08%6.85M
--3.31M
Accounts receivable
127.68%12.8M
--16.09M
--5.62M
----
----
----
----
----
----
Advance deposits and other receivables
45.09%114.86M
49.88%135.13M
-20.42%79.17M
143.68%90.15M
90.38%99.48M
85.09%37M
--52.25M
23.77%19.99M
--16.15M
Cash and equivalents
-36.34%709.91M
40.88%851.03M
-5.18%1.12B
-60.27%604.07M
41.09%1.18B
662.56%1.52B
--833.61M
-53.91%199.41M
--432.61M
Fixed time deposit-current assets
8.32%1.73B
-27.59%1.69B
-25.50%1.6B
19.92%2.34B
1,829.77%2.14B
1,251.94%1.95B
--111.06M
--144.28M
----
Secured deposit
----
--1.78M
----
----
----
----
----
----
----
Financial assets at fair value-current assets
-48.56%137.28M
-24.90%174.37M
158.97%266.85M
334.80%232.19M
40.20%103.05M
413.77%53.4M
--73.5M
-84.33%10.39M
--66.34M
Total current assets
-11.39%2.79B
-11.19%2.94B
-11.61%3.15B
-7.59%3.31B
226.31%3.56B
840.35%3.58B
--1.09B
-26.52%380.92M
--518.41M
Non-current assets
Property, plant and equipment
11.15%864.43M
45.12%803.35M
98.39%777.73M
297.04%553.56M
275.16%392.02M
38.05%139.42M
--104.49M
4.69%100.99M
--96.47M
Advance payment
159.13%46.36M
69.90%26.91M
-79.88%17.89M
-89.69%15.84M
146.19%88.91M
537.20%153.59M
--36.11M
62.80%24.1M
--14.81M
Interests in Joint Venture
-51.33%4.12M
-44.92%5.82M
-26.13%8.47M
-47.88%10.57M
--11.47M
--20.28M
----
----
----
Intangible assets
92.71%2.51M
-25.80%1.11M
-16.04%1.3M
35.51%1.5M
448.41%1.55M
912.84%1.1M
--283K
--109K
----
Total non-current assets
10.43%1.02B
51.59%943.39M
69.49%921.08M
76.55%622.34M
222.52%543.43M
136.54%352.51M
--168.5M
6.32%149.03M
--140.17M
Total assets
-6.45%3.81B
-1.26%3.88B
-0.87%4.07B
-0.05%3.93B
225.80%4.1B
642.43%3.93B
--1.26B
-19.53%529.95M
--658.58M
Liabilities
Current liabilities
Accounts payable
-11.75%30.07M
97.73%29.49M
246.14%34.07M
435.67%14.91M
202.46%9.84M
-18.55%2.78M
--3.25M
-1.73%3.42M
--3.48M
Tax payable
--4.99M
----
----
----
----
----
----
----
----
Amounts payable to associated parties-current liabilities
----
----
----
-59.31%225K
--553K
-98.69%553K
----
-11.26%42.37M
--47.75M
Other payables and accrued expenses
0.18%165.4M
50.09%219.44M
103.38%165.1M
53.25%146.21M
91.29%81.18M
391.81%95.4M
--42.44M
33.83%19.4M
--14.5M
Bank loans and overdrafts
2,823.64%343.76M
-25.08%45.83M
-88.24%11.76M
--61.16M
--100M
----
----
----
----
Financial lease liabilities-current liabilities
-14.30%15.45M
75.37%19.43M
44.22%18.03M
-5.51%11.08M
107.78%12.5M
180.61%11.72M
--6.02M
-5.69%4.18M
--4.43M
Deferred income-current liabilities
----
----
----
----
-22.48%2.23M
-43.89%1.61M
--2.88M
99.51%2.87M
--1.44M
Total current liabilities
144.44%559.66M
-17.26%314.18M
-34.21%228.95M
238.79%379.7M
162.00%348.01M
39.67%112.08M
--132.83M
12.08%80.24M
--71.59M
Net current assets
-23.62%2.23B
-10.41%2.63B
-9.16%2.92B
-15.55%2.93B
235.22%3.21B
1,054.02%3.47B
--958.14M
-32.71%300.68M
--446.82M
Total assets less current liabilities
-15.45%3.25B
0.45%3.57B
2.22%3.84B
-7.06%3.55B
233.32%3.76B
749.97%3.82B
--1.13B
-23.39%449.71M
--586.99M
Non-current liabilities
Long-term bank loan
28.60%348.65M
1,052.20%331.83M
2,611.02%271.1M
--28.8M
--10M
----
----
----
----
Financial lease liabilities-non-current liabilities
-46.44%16.34M
3.32%21.62M
11.08%30.52M
-22.45%20.93M
18.96%27.47M
32.84%26.99M
--23.09M
-16.30%20.31M
--24.27M
Deferred tax liability
--463K
--278K
----
----
----
----
----
----
----
Deferred income-non-current liabilities
49.31%243.18M
39.42%228.19M
90.82%162.87M
1,777.18%163.67M
870.68%85.35M
28.49%8.72M
--8.79M
327.60%6.79M
--1.59M
Convertible notes and bonds
----
----
----
----
----
----
--5.58B
88.99%1.39B
--733.26M
Total non-current liabilities
31.03%608.63M
172.70%581.93M
278.17%464.48M
20.57%213.4M
-97.86%122.82M
-88.54%177M
--5.75B
78.98%1.54B
--862.94M
Total liabilities
68.48%1.17B
51.09%896.11M
47.28%693.44M
105.17%593.1M
-92.00%470.83M
-82.21%289.07M
--5.89B
73.86%1.62B
--934.53M
Total assets less total liabilities
-21.85%2.64B
-10.55%2.99B
-7.11%3.37B
-8.40%3.34B
178.53%3.63B
432.97%3.65B
---4.63B
-296.73%-1.09B
---275.96M
Total equity and non-current liabilities
-15.45%3.25B
0.45%3.57B
2.22%3.84B
-7.06%3.55B
233.32%3.76B
749.97%3.82B
--1.13B
-23.39%449.71M
--586.99M
Equity
Share capital
2.96%174K
-0.59%169K
-1.17%169K
-0.58%170K
280.00%171K
280.00%171K
--45K
0.00%45K
--45K
Reserve
-21.86%2.64B
-10.60%2.99B
-8.30%3.37B
-8.51%3.34B
--3.68B
433.53%3.65B
----
---1.09B
----
Special items of shareholders' rights and interests
----
----
----
----
----
----
---4.62B
----
---276M
Shareholders' Equity
-21.86%2.64B
-10.60%2.99B
-7.33%3.37B
-8.51%3.34B
178.75%3.64B
433.56%3.65B
---4.62B
-296.64%-1.09B
---275.96M
Non-controlling interest
311.11%444K
146.92%502K
101.27%108K
80.85%-1.07M
-287.89%-8.52M
-2,008.68%-5.59M
---2.2M
---265K
----
Total equity
-21.85%2.64B
-10.55%2.99B
-7.11%3.37B
-8.40%3.34B
178.53%3.63B
432.97%3.65B
---4.63B
-296.73%-1.09B
---275.96M
Total equity and total liabilities
-6.45%3.81B
-1.26%3.88B
-0.87%4.07B
-0.05%3.93B
225.80%4.1B
642.43%3.93B
--1.26B
-19.53%529.95M
--658.58M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Assets
Current assets
Inventory 4.35%83.93M26.65%56.35M111.82%80.43M171.43%44.5M84.84%37.97M139.45%16.39M--20.54M107.08%6.85M--3.31M
Accounts receivable 127.68%12.8M--16.09M--5.62M------------------------
Advance deposits and other receivables 45.09%114.86M49.88%135.13M-20.42%79.17M143.68%90.15M90.38%99.48M85.09%37M--52.25M23.77%19.99M--16.15M
Cash and equivalents -36.34%709.91M40.88%851.03M-5.18%1.12B-60.27%604.07M41.09%1.18B662.56%1.52B--833.61M-53.91%199.41M--432.61M
Fixed time deposit-current assets 8.32%1.73B-27.59%1.69B-25.50%1.6B19.92%2.34B1,829.77%2.14B1,251.94%1.95B--111.06M--144.28M----
Secured deposit ------1.78M----------------------------
Financial assets at fair value-current assets -48.56%137.28M-24.90%174.37M158.97%266.85M334.80%232.19M40.20%103.05M413.77%53.4M--73.5M-84.33%10.39M--66.34M
Total current assets -11.39%2.79B-11.19%2.94B-11.61%3.15B-7.59%3.31B226.31%3.56B840.35%3.58B--1.09B-26.52%380.92M--518.41M
Non-current assets
Property, plant and equipment 11.15%864.43M45.12%803.35M98.39%777.73M297.04%553.56M275.16%392.02M38.05%139.42M--104.49M4.69%100.99M--96.47M
Advance payment 159.13%46.36M69.90%26.91M-79.88%17.89M-89.69%15.84M146.19%88.91M537.20%153.59M--36.11M62.80%24.1M--14.81M
Interests in Joint Venture -51.33%4.12M-44.92%5.82M-26.13%8.47M-47.88%10.57M--11.47M--20.28M------------
Intangible assets 92.71%2.51M-25.80%1.11M-16.04%1.3M35.51%1.5M448.41%1.55M912.84%1.1M--283K--109K----
Total non-current assets 10.43%1.02B51.59%943.39M69.49%921.08M76.55%622.34M222.52%543.43M136.54%352.51M--168.5M6.32%149.03M--140.17M
Total assets -6.45%3.81B-1.26%3.88B-0.87%4.07B-0.05%3.93B225.80%4.1B642.43%3.93B--1.26B-19.53%529.95M--658.58M
Liabilities
Current liabilities
Accounts payable -11.75%30.07M97.73%29.49M246.14%34.07M435.67%14.91M202.46%9.84M-18.55%2.78M--3.25M-1.73%3.42M--3.48M
Tax payable --4.99M--------------------------------
Amounts payable to associated parties-current liabilities -------------59.31%225K--553K-98.69%553K-----11.26%42.37M--47.75M
Other payables and accrued expenses 0.18%165.4M50.09%219.44M103.38%165.1M53.25%146.21M91.29%81.18M391.81%95.4M--42.44M33.83%19.4M--14.5M
Bank loans and overdrafts 2,823.64%343.76M-25.08%45.83M-88.24%11.76M--61.16M--100M----------------
Financial lease liabilities-current liabilities -14.30%15.45M75.37%19.43M44.22%18.03M-5.51%11.08M107.78%12.5M180.61%11.72M--6.02M-5.69%4.18M--4.43M
Deferred income-current liabilities -----------------22.48%2.23M-43.89%1.61M--2.88M99.51%2.87M--1.44M
Total current liabilities 144.44%559.66M-17.26%314.18M-34.21%228.95M238.79%379.7M162.00%348.01M39.67%112.08M--132.83M12.08%80.24M--71.59M
Net current assets -23.62%2.23B-10.41%2.63B-9.16%2.92B-15.55%2.93B235.22%3.21B1,054.02%3.47B--958.14M-32.71%300.68M--446.82M
Total assets less current liabilities -15.45%3.25B0.45%3.57B2.22%3.84B-7.06%3.55B233.32%3.76B749.97%3.82B--1.13B-23.39%449.71M--586.99M
Non-current liabilities
Long-term bank loan 28.60%348.65M1,052.20%331.83M2,611.02%271.1M--28.8M--10M----------------
Financial lease liabilities-non-current liabilities -46.44%16.34M3.32%21.62M11.08%30.52M-22.45%20.93M18.96%27.47M32.84%26.99M--23.09M-16.30%20.31M--24.27M
Deferred tax liability --463K--278K----------------------------
Deferred income-non-current liabilities 49.31%243.18M39.42%228.19M90.82%162.87M1,777.18%163.67M870.68%85.35M28.49%8.72M--8.79M327.60%6.79M--1.59M
Convertible notes and bonds --------------------------5.58B88.99%1.39B--733.26M
Total non-current liabilities 31.03%608.63M172.70%581.93M278.17%464.48M20.57%213.4M-97.86%122.82M-88.54%177M--5.75B78.98%1.54B--862.94M
Total liabilities 68.48%1.17B51.09%896.11M47.28%693.44M105.17%593.1M-92.00%470.83M-82.21%289.07M--5.89B73.86%1.62B--934.53M
Total assets less total liabilities -21.85%2.64B-10.55%2.99B-7.11%3.37B-8.40%3.34B178.53%3.63B432.97%3.65B---4.63B-296.73%-1.09B---275.96M
Total equity and non-current liabilities -15.45%3.25B0.45%3.57B2.22%3.84B-7.06%3.55B233.32%3.76B749.97%3.82B--1.13B-23.39%449.71M--586.99M
Equity
Share capital 2.96%174K-0.59%169K-1.17%169K-0.58%170K280.00%171K280.00%171K--45K0.00%45K--45K
Reserve -21.86%2.64B-10.60%2.99B-8.30%3.37B-8.51%3.34B--3.68B433.53%3.65B-------1.09B----
Special items of shareholders' rights and interests ---------------------------4.62B-------276M
Shareholders' Equity -21.86%2.64B-10.60%2.99B-7.33%3.37B-8.51%3.34B178.75%3.64B433.56%3.65B---4.62B-296.64%-1.09B---275.96M
Non-controlling interest 311.11%444K146.92%502K101.27%108K80.85%-1.07M-287.89%-8.52M-2,008.68%-5.59M---2.2M---265K----
Total equity -21.85%2.64B-10.55%2.99B-7.11%3.37B-8.40%3.34B178.53%3.63B432.97%3.65B---4.63B-296.73%-1.09B---275.96M
Total equity and total liabilities -6.45%3.81B-1.26%3.88B-0.87%4.07B-0.05%3.93B225.80%4.1B642.43%3.93B--1.26B-19.53%529.95M--658.58M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday-1.08%
Biotechnology
Biotechnology
Intraday-1.53%